Center-Authored Papers

Filters: Author is Storb, R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Appelbaum FR, Badger CC, Bernstein ID, Buckner CD, Deeg HJ, Eary JF, Matthews DC, Press OW, Storb R, Thomas ED.  1992.  Is there a better way to deliver total body irradiation? Bone marrow transplantation. 10 Suppl 1:77-81. Abstract
Au BKC, Gooley TA, Armand P, Fang M, Madtes DK, Sorror ML, Boeckh MJ, Gibson CJ, Deeg HJ, Storb R et al..  2015.  Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(5):848-54. Abstract
B
Bar M, Sandmaier BM, Inamoto Y, Bruno B, Hari P, Chauncey T, Martin P, Storb R, Maloney DG, Storer B et al..  2013.  Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3(+) T Cell Dose.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(6):949-957. Abstract
Baron F, Storb R.  2012.  Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(6):822-40. Abstract
Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers MED, Mielcarek M et al..  2005.  Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(9):1993-2003. Abstract
Baron F, Petersdorf EW, Gooley TA, Sandmaier BM, Malkki M, Chauncey TR, Maloney DG, Storb R.  2009.  What is the role for donor natural killer cells after nonmyeloablative conditioning? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(5):580-8. Abstract
Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little M-T, Maloney DG, Storb R et al..  2005.  High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 19(5):822-8. Abstract
Bensinger WI, Rotta M, Storer B, Chauncey T, Holmberg L, Becker P, Sandmaier BM, Storb R, Maloney D.  2012.  Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.. Bone marrow transplantation. 47(10):1312-7. Abstract
Bethge WA, Kerbauy FR, Santos EB, Gooley T, Storb R, Sandmaier BM.  2014.  Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.. Bone marrow transplantation. 49(9):1198-204. Abstract
Bethge WA, Kerbauy FR, Santos E, Gooley TA, Storb R, Sandmaier BM.  2011.  Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.. Bone marrow transplantation. 46(10):1382-8. Abstract
Bowen JD, Kraft GH, Wundes A, Guan Q, Maravilla KR, Gooley TA, McSweeney PA, Pavletic SZ, Openshaw H, Storb R et al..  2012.  Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.. Bone marrow transplantation. 47(7):946-951. Abstract
Bruno B, Rotta M, Patriarca F, Mattei D, Allione B, Carnevale-Schianca F, Sorasio R, Rambaldi A, Casini M, Parma M et al..  2009.  Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.. Blood. 113(14):3375-82. Abstract
Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW et al..  1996.  High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.. Bone marrow transplantation. 18(1):131-41. Abstract
Burroughs L, Mielcarek M, Leisenring W, Sandmaier BM, Maloney DG, Baron F, Martin PJ, Flowers MED, Forman SJ, Chauncey TR et al..  2006.  Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.. Transplantation. 81(6):818-25. Abstract
Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano J-A, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S et al..  2014.  Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(12):1996-2003. Abstract
Burroughs LM, Shimamura A, Talano J-A, Domm J, Baker K, Delaney C, Frangoul H, Margolis D, Baker KS, Geddis A et al..  2017.  Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Burroughs LM, Woolfrey AE, Storer BE, Deeg HJ, Flowers MED, Martin PJ, Carpenter PA, Doney K, Appelbaum FR, Sanders JE et al..  2012.  Success of allogeneic marrow transplantation for children with severe aplastic anaemia.. British journal of haematology. 158(1):120-8. Abstract
Burroughs LM, O'Donnell PV, Sandmaier BM, Storer BE, Luznik L, Symons HJ, Jones RJ, Ambinder RF, Maris MB, Blume KG et al..  2008.  Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1279-87. Abstract
Burroughs LM, Torgerson TR, Storb R, Carpenter PA, Rawlings DJ, Sanders JE, Scharenberg AM, Skoda-Smith S, Englund J, Ochs HD et al..  2010.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.. The Journal of allergy and clinical immunology. 126(5):1000-5. Abstract
Burroughs L, Mielcarek M, Little M-T, Bridger G, Macfarland R, Fricker S, Labrecque J, Sandmaier BM, Storb R.  2005.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.. Blood. 106(12):4002-8. Abstract
C
Carnevale-Schianca F, Leisenring WM, Martin PJ, Furlong T, Schoch G, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Kiem H-P et al..  2009.  Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(6):749-56. Abstract
Cassaday RD, Alan Potts D, Stevenson PA, Bar M, Georges GE, Shustov AR, Sorror ML, Wood BL, Delaney C, Doney KC et al..  2016.  Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.. Leukemia & lymphoma. :1-10. Abstract
Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Maloney DG, Rajendran JG, Pagel JM, Flowers ME, Green DJ et al..  2015.  Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):281-7. Abstract
Castermans E, Hannon M, Dutrieux J, Humblet-Baron S, Seidel L, Cheynier R, Willems E, Gothot A, Vanbellinghen J-F, Geenen V et al..  2011.  Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.. Haematologica. 96(2):298-306. Abstract
Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, Mielcarek M, Shulman H, Storb R, Nash RA.  2014.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 49(7):966-71. Abstract